Treatment for benign prostatic hypertrophy in Bekasi, find doctors near you. Book Appointment Online, View Fees, Reviews Doctors for Benign Prostatic. Benigna Hipertrofi Prostat / Benigna Prostatik Hyperplasia (BPH) yaitu pembesaran jinak kelenjar prostat, disebabkan karena hiperplasia beberapa atau semua. Hipertrofi prostat benigna / pembesaran prostat jinak merupakan penyakit pada pria tua dan jarang ditemukan pada usia sebelum 40 tahun. Prostat normal.
|Country:||United Arab Emirates|
|Published (Last):||25 May 2014|
|PDF File Size:||9.70 Mb|
|ePub File Size:||14.25 Mb|
|Price:||Free* [*Free Regsitration Required]|
Archived from the original on 6 October Aromatase and 5-alpha reductase are responsible for converting androgen hormones into estrogen and dihydrotestosteronerespectively.
Retrieved 11 Jijak A Systematic Review and Meta-Analysis”.
The older, broadly non-selective alpha blocker medications such as phenoxybenzamine are not recommended for control of BPH. Incidence rates increase from 3 cases per man-years at age 45—49 years, to 38 cases per man-years by the age of 75—79 years. University of Maryland Medical Center.
The clinical diagnosis of BPH is based on a history of LUTS lower urinary tract symptomsa digital rectal exam, and exclusion of other causes of similar signs and symptoms. FDA — Drug Documents.
Incomplete voiding results in residual urine or urinary stasis, which can lead to an increased risk of urinary tract infection. Dihydrotestosterone DHTa metabolite of testosterone, is a critical mediator of prostatic growth. Retrieved 2 March Retrieved 27 January BPH is the most common cause of lower urinary tract symptoms LUTSwhich are divided into storage, voiding, and symptoms which occur after urination.
Archived from the original on 11 November The prostate gets larger in most men as they get older. Micrograph showing nodular hyperplasia left off center of the prostate from a transurethral resection of the prostate TURP.
Benign prostatic hyperplasia – Wikipedia
Retrieved 7 May D ICD – Frequent urination, trouble starting to urinate, weak stream, inability to urinateloss of bladder control . Retrieved 2 February Archived from the original on 3 April Archived PDF from the original on 14 July As men age, the enzymes aromatase and 5-alpha reductase increase in activity. Cochrane Database Syst Rev. Misrepair-accumulation aging theory   suggests that development of benign prostatic hyperplasia is a consequence of fibrosis and weakening of the muscular tissue in the prostate.
Retrieved 14 November While there is some evidence that estrogen may play a role in the cause of BPH, this effect appears to be mediated mainly through local conversion of androgens to estrogen in the prostate tissue rather than a direct effect of estrogen itself. Benign prostatic hyperplasia is an age-related disease.
Wilt, Timothy J, ed. Effects may take longer to appear than alpha blockers, but they persist for many years. Phosphodiesterase-5 inhibitors such as sildenafil citrate show some symptomatic relief, suggesting a possible common cause with erectile dysfunction. Heart failurediabetesprostate cancer .
Benign prostatic hyperplasia
Such misrepairs make the muscular tissue weak in functioning, and the fluid secreted by hipertrogi cannot be excreted completely. A systematic review of efficacy and adverse effects”.
Retrieved 26 October Lifestyle alterations to address the symptoms of BPH include physical activity,  decreasing fluid intake before bedtime, moderating the consumption of alcohol and caffeine-containing products and following a timed voiding schedule. The Journal of the American Medical Association.
Diagram of a normal prostate left and benign prostatic hyperplasia right.